Trial Profile
Safety and Efficacy of Propranolol Eye Drops in Newborns With Retinopathy of Premature (DROP-PROP)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2017
Price :
$35
*
At a glance
- Drugs Propranolol (Primary)
- Indications Retinopathy of prematurity
- Focus Adverse reactions; Therapeutic Use
- Acronyms DROP-PROP
- 07 Mar 2017 New trial record